Athena Athena

X

Find the latest news about Selecta Biosciences aggregated by PharmaCompass.com.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Selecta Biosciences
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
480 Arsenal Way Watertown, MA 02472
Telephone
Telephone
617-923-1400
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.fiercebiotech.com/biotech/selecta-fuses-cartesian-reverse-merger-bolstering-finances-autoimmune-cell-therapy-goals

Max Bayer FIERCE BIOTECH
13 Nov 2023

https://www.globenewswire.com//news-release/2023/11/13/2779033/0/en/Selecta-Biosciences-Announces-Merger-with-Cartesian-Therapeutics.html

GLOBENEWSWIRE
13 Nov 2023

https://www.globenewswire.com//news-release/2023/10/31/2770616/0/en/Selecta-Announces-Transition-of-Manufacturing-and-Clinical-Operations-of-ImmTOR-for-SEL-212-to-Commercialization-Partner-Sobi.html

GLOBENEWSWIRE
31 Oct 2023

https://www.globenewswire.com//news-release/2023/08/17/2727105/0/en/Selecta-Biosciences-Reports-Second-Quarter-2023-Financial-Results-and-Updates-on-Strategic-Initiative-Designed-to-Maximize-Stockholder-Value-Associated-with-SEL-212-Economics.html

GLOBENEWSWIRE
17 Aug 2023

https://www.fiercebiotech.com/biotech/selecta-narrows-focus-gout-drug-freezing-investment-rest-pipeline

James Waldron FIERCE BIOTECH
17 Aug 2023

https://www.globenewswire.com/news-release/2023/05/31/2679221/0/en/Selecta-Biosciences-Announces-Presentation-of-Data-from-Phase-3-DISSOLVE-Program-of-SEL-212-in-Chronic-Refractory-Gout-During-Late-Breaking-Session-at-the-EULAR-2023-European-Congr.html

GLOBENEWSWIRE
31 May 2023

https://endpts.com/selecta-lays-off-25-of-employees-after-strategic-review/

Paul Schloesser ENDPTS
04 May 2023

https://www.globenewswire.com/news-release/2023/05/04/2661387/0/en/Selecta-Biosciences-Reports-First-Quarter-2023-Financial-Results-and-Provides-Business-Update.html

GLOBENEWSWIRE
04 May 2023

https://www.fiercebiotech.com/biotech/planning-challenge-horizon-selecta-and-sobi-rout-gout-pair-phase-3-trials

Nick Paul Taylor FIERCE BIOTECH
22 Mar 2023

https://www.globenewswire.com/news-release/2023/03/21/2630995/0/en/Phase-3-DISSOLVE-Program-of-SEL-212-in-Chronic-Refractory-Gout-Meets-Primary-Endpoint.html

GLOBENEWSWIRE
21 Mar 2023
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY